Literature DB >> 9890038

In ovo vaccination technology.

C A Ricks1, A Avakian, T Bryan, R Gildersleeve, E Haddad, R Ilich, S King, L Murray, P Phelps, R Poston, C Whitfill, C Williams.   

Abstract

More than 80% of the U.S. broiler industry has converted to the in ovo vaccination process for control of Marek's disease. Providing certain criteria are met, including timing and site of vaccine placement, vaccine mixing, machine sanitization, and hatchery management specifications, this has proven to be an efficacious and convenient method of vaccination. Efforts to extend the technology for other viral vaccines including Newcastle, bronchitis and bursal disease, and bacterial and parasitic vaccines are in progress. Collectively, these studies demonstrate that in ovo vaccination technology using approved vaccine is a safe, efficacious, and convenient method for vaccination of poultry.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890038

Source DB:  PubMed          Journal:  Adv Vet Med        ISSN: 1093-975X


  14 in total

1.  Changes in antimicrobial susceptibility of native Enterococcus faecium in chickens fed virginiamycin.

Authors:  Patrick F McDermott; Patti Cullen; Susannah K Hubert; Shawn D McDermott; Mary Bartholomew; Shabbir Simjee; David D Wagner
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

2.  An observational study of the temporal and spatial patterns of Marek's-disease-associated leukosis condemnation of young chickens in the United States of America.

Authors:  David A Kennedy; John R Dunn; Patricia A Dunn; Andrew F Read
Journal:  Prev Vet Med       Date:  2015-05-08       Impact factor: 2.670

3.  Incidence and characterization of integrons, genetic elements mediating multiple-drug resistance, in avian Escherichia coli.

Authors:  L Bass; C A Liebert; M D Lee; A O Summers; D G White; S G Thayer; J J Maurer
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

4.  Delayed vaccine virus replication in chickens vaccinated subcutaneously with an immune complex infectious bursal disease vaccine: quantification of vaccine virus by real-time polymerase chain reaction.

Authors:  Judit Iván; Maja Velhner; Krisztina Ursu; Péter German; Tamás Mató; Csaba Nick Drén; János Mészáros
Journal:  Can J Vet Res       Date:  2005-04       Impact factor: 1.310

5.  Protective immunity against Eimeria acervulina following in ovo immunization with a recombinant subunit vaccine and cytokine genes.

Authors:  Xicheng Ding; Hyun S Lillehoj; Marco A Quiroz; Erich Bevensee; Erik P Lillehoj
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

6.  Progress toward the development of polyvalent vaccination strategies against multiple viral infections in chickens using herpesvirus of turkeys as vector.

Authors:  Munir Iqbal
Journal:  Bioengineered       Date:  2012-06-18       Impact factor: 3.269

7.  Improved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses.

Authors:  Yibin Cai; Haichen Song; Jianqiang Ye; Hongxia Shao; Rangarajan Padmanabhan; Troy C Sutton; Daniel R Perez
Journal:  Virol J       Date:  2011-01-21       Impact factor: 4.099

8.  In ovo vaccination using Eimeria profilin and Clostridium perfringens NetB proteins in Montanide IMS adjuvant increases protective immunity against experimentally-induced necrotic enteritis.

Authors:  Hyun Soon Lillehoj; Seung Ik Jang; Alfredo Panebra; Erik Peter Lillehoj; Laurent Dupuis; Juliette Ben Arous; Seung Kyoo Lee; Sung Taek Oh
Journal:  Asian-Australas J Anim Sci       Date:  2017-03-21       Impact factor: 2.509

9.  Protection against avian necrotic enteritis after immunisation with NetB genetic or formaldehyde toxoids.

Authors:  Sérgio P Fernandes da Costa; Dorien Mot; Monika Bokori-Brown; Christos G Savva; Ajit K Basak; Filip Van Immerseel; Richard W Titball
Journal:  Vaccine       Date:  2013-05-29       Impact factor: 3.641

10.  Protective effect of in ovo treatment with the chicken cathelicidin analog D-CATH-2 against avian pathogenic E. coli.

Authors:  Tryntsje Cuperus; Albert van Dijk; Mieke G R Matthijs; Edwin J A Veldhuizen; Henk P Haagsman
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.